SCHEMBL19633443

SCHEMBL19633443

CC1CC(C(=O)C2C(=O)CC(C)(C)OC2O)CCN1C(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.35
RECQL P46063 1/20 0.35
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.33
PTPN2 P17706 1/20 0.33
PTPN1 P18031 1/20 0.33
PTPN6 P29350 1/20 0.33
SETD7 Q8WTS6 1/20 0.32
STS P08842 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM1 P11229 1/20 0.32
CHRM3 P20309 1/20 0.32
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31
DDB1 Q16531 1/20 0.31
CRBN Q96SW2 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19628322 0.81 GPR119 (0.35) GPR119RECQLHPGDHSD17B10PTPN2
SCHEMBL31001845 0.76 GPR119 (0.37) GPR119RECQLHPGDHSD17B10PTPN2
SCHEMBL16680966 0.76 GPR119 (0.37) GPR119RECQLHPGDHSD17B10PTPN2
SCHEMBL31001854 0.76 GPR119 (0.37) GPR119RECQLHPGDHSD17B10PTPN2
SCHEMBL16680969 0.76 GPR119 (0.37) GPR119RECQLHPGDHSD17B10PTPN2
SCHEMBL23694159 0.71 HSD17B10 (0.44) GPR119RECQLHPGDHSD17B10PTPN2
SCHEMBL16680566 0.71 HSD17B10 (0.53) GPR119RECQLHPGDHSD17B10PTPN2
SCHEMBL23694162 0.71 HSD17B10 (0.44) GPR119RECQLHPGDHSD17B10PTPN2
SCHEMBL6774754 0.71 HSD17B10 (0.44) GPR119RECQLHPGDHSD17B10PTPN2
SCHEMBL24927723 0.71 HSD17B10 (0.53) GPR119RECQLHPGDHSD17B10PTPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170334917-A1 PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334917-A1 PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE HAMP, SERPINC1, PRSS8 GPR119 4770/4885RECQL 1094/4885HPGD 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.